Conference Reports for NATAP

EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom  April 9-13 Back

SVR AND SAFETY OF LOWER DOSES OF MK-5172 25 MG AND 50 MG DAILY FOR 12 WEEKS IN HCV GENOTYPE (G)1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS       Reported by Jules Levin EASL 2014 April 9-10 London, UK   Martin Lagging, Ashley Brown, Ola Weiland, Parvez Mantry, Alnoor Ramji, Frank Weilert, John M. Vierling, Anita Howe, Jennifer Talaty, Isaias Noel Gendrano III, Peggy Hwang, Boan Zhang, Janice Wahl, Michael Robertson, Niloufar Mobashery